JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics

Blood Adv. 2017 Jun 12;1(14):968-971. doi: 10.1182/bloodadvances.2017007047. eCollection 2017 Jun 13.

Thomas McKerrell^{1

2

3}, Naomi Park¹, Jianxiang Chi^{4

5}, Grace Collord¹, Thaidy Moreno⁶, Hannes Ponstingl¹, Joao Dias⁷, Petroula Gerasimou^{4

5}, Kiki Melanthiou⁸, Chrystalla Prokopiou⁹, Marios Antoniades⁸, Ignacio Varela⁶, Paul A Costeas^{4

5}, George S Vassiliou^{1

2

3

4}

¹ The Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
² Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
³ Department of Haematology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom.
⁴ The Center for the Study of Haematological Malignancies, Nicosia, Cyprus.
⁵ The Karaiskakio Foundation, Nicosia, Cyprus.
⁶ Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.
⁷ Cancer Molecular Diagnosis Laboratory, National Institute for Health Research Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
⁸ Department of Haematology, Nicosia General Hospital, Nicosia, Cyprus; and.
⁹ Department of Haematology, Limassol General Hospital, Limassol, Cyprus.

No abstract available

Grants and funding